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Background: Gamma oscillations serve complex processes, and the first stage of their generation is the reticular
activating system (RAS), which mediates the gamma-activity states of waking and paradoxical sleep. We studied
whether the pedunculopontine nucleus (PPN), part of the RAS in which every cell manifests intrinsic gamma
oscillations, undergoes changes resulting in distinctive protein expression.
New method: We previously found that a histone deacetylation inhibitor, trichostatin A (TSA), acutely (30 min)
blocked these oscillations. We developed a proteomic method for sampling stimulated and unstimulated PPN and
determining protein expression in 1 mm punches of tissue from brain slices subjected to various treatments.
Results: We compared brain slices exposed for 30 min to TSA (unstimulated), to the cholinergic agonist carbachol
(CAR), known to induce PPN gamma oscillations, or exposed to both TSA þ CAR.
Comparison with existing methods: Label-free proteomics provides an unbiased and sensitive method to detect
protein changes in the PPN. Our approach is superior to antibody-based methods that can lack specificity and can
only be done for known targets. Proteomics methods like these have been leveraged to study molecular pathways
in numerous systems and disease states.
Conclusions: Significant protein changes were seen in two functions essential to the physiology of the PPN:
cytoskeletal and intracellular [Ca2þ] regulation proteins. TSA decreased, while CAR increased, and TSA þ CAR
had intermediate effects, on expression of these proteins. These results support the feasibility of the methods
developed for determining proteomic changes in small samples of tissue participating in the most complex of
brain processes.1. Introduction
Without high frequency beta/gamma activity there is no purposeful
brain function. Without such activity there is no sensation, perception,
memory, movement, thought, or action (Eckhorn et al., 1988; Gray and
Singer, 1989; Jones, 2007; Llinas et al., 1991; Palva et al., 2009; Philips
and Takeda, 2009; Singer, 1993; Voss et al., 2009). Low frequency ac-
tivity in the brain at rest is ~10 Hz (alpha), the idling speed of the brain.
If activity is slower, there is only sleep, nobody home. Without beta/-
gamma activity, there is no consciousness (Garcia-Rill, 2015). Beta/-
gamma activity in the reticular activating system (RAS), and specifically
the pedunculopontine nucleus (PPN), is the first stage in which sensory
input revs up brain activity, it has been termed “bottom-up gamma”,
responsible for setting the background of activity for sensation,rcia-Rill).
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high frequency activity is generated by high threshold,
voltage-dependent calcium channels (the action of sodium and potassium
channels in the PPN is simply too slow to generate such high frequency
activity) (Kezunovic et al., 2011). This “bottom-up gamma” is relayed
through the intralaminar thalamus and basal forebrain, and triggers
cortical gamma band activity (Castro et al., 2013; Cavelli et al., 2017).
Without “bottom-up gamma” there is no waking, no arousal, no cogent
state upon which to decide to think or move. That is, without gamma
oscillations, there is no thought or behavior.
A significant problem with proteomic and genomic analyses of the
brain is the variety of cell types manifesting a myriad of receptors and a
host of ionic channels. This makes it difficult to ascribe changes in pro-
tein levels and gene expression. In the current study, the preparation we2019
rticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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gamma oscillations, Kezunovic et al., 2011; Urbano et al., 2018) to
ensure that fast synaptic transmission and circuit activity through action
potentials was prevented. The activity present in the system, therefore,
was mainly from intrinsic membrane oscillations, and limited to high
frequency gamma oscillations mainly in cells manifesting P/Q-and
N-type type channels. As such, proteomic and genomic changes may be
more easily ascribed to specific processes related to the generation of
gamma band activity.
The pedunculopontine nucleus (PPN) is the only nucleus in the RAS
that is active during both states of high frequency (beta/gamma) EEG
activity as in waking and REM sleep. Classic studies of recordings of PPN
neurons during sleep-wake states revealed neurons that were active
during waking and REM sleep, and none were active during slow wave
sleep (Sakai et al., 1990; Steriade et al., 1990; Kayama et al., 1992; Datta
and Siwek, 2002; Datta et al., 2009; Boucetta et al., 2014). Gamma band
activity has been observed in the cortical EEG of the cat in vivo and in PPN
neurons when the animal is active (Steriade et al., 1990). Additionally, in
humans, gamma band activity has been shown in the region of the PPN
during stepping, but not at rest (Fraix et al., 2008). Primates have also
been observed to have PPN firing at low frequencies ~10 Hz at rest, but
upon waking or walking on a treadmill firing is increased to gamma band
frequencies (Goetz et al., 2016). Thus, the same cells were involved in
both arousal and motor control in the PPN in vitro, in vivo, and across
species, including man.
Our previous findings established that every PPN neuron fired
maximally at beta/gamma frequencies (Simon et al., 2010), that all PPN
neurons manifested beta/gamma frequency intrinsic membrane oscilla-
tions (Urbano et al., 2012), and that these oscillations were mediated
only by high threshold, voltage-dependent N- and/or P/Q-type calcium
channels (Kezunovic et al., 2011). We found that these channels were
distributed along the dendrites of PPN neurons (Hyde et al., 2013), and
that some cells exhibited both N- and P/Q-type calcium channels, some
had only N-type channels, and some had only P/Q-type channels (Luster
et al., 2015, 2016).
Our most recent results showed that, a) acute in vitro exposure to the
histone deacetylation inhibitor trichostatin A (TSA) led to the elimina-
tion of high threshold, voltage-dependent Ca2þ channel-mediated
intrinsic membrane oscillations, specifically in the gamma band range,
but not lower frequency oscillations, b) pre-incubation with TSA led to a
similar decrease specifically in gamma band oscillations, and c) a sig-
nificant reduction in calcium currents was elicited by TSA (Urbano et al.,
2018). These results suggest that there is a specific effect on gamma band
oscillations when histone deacetylation is maximally blocked after >30
min. Thus, this work aims to develop a new method for determining
proteomic changes in small samples of tissue. Changes in protein levels
resulting from this newly described protocol can be correlated to previ-
ously described alterations in gamma oscillations (Kezunovic et al., 2013;
Urbano et al., 2018).
2. Materials and methods
2.1. Slice preparation
Pups aged 9–13 days from adult timed-pregnant Sprague-Dawley rats
(280–350 g) were anesthetized with ketamine (70 mg/kg, I.M.) until tail
pinch reflex was absent. Pups were decapitated and the brain was rapidly
removed then cooled in oxygenated sucrose-artificial cerebrospinal fluid
(sucrose-aCSF). The sucrose-aCSF consisted of (in mM): 233.7 sucrose, 26
NaHCO3, 3 KCl, 8 MgCl2, 0.5 CaCl2, 20 glucose, 0.4 ascorbic acid, and 2
sodium pyruvate. Sagittal sections (400 um) containing the PPN were cut
and slices were allowed to equilibrate in normal aCSF at room temper-
ature. Approximately 4 slices per brain contained the PPN. The aCSF was
composed of (in mM): 117 NaCl, 4.7 KCl, 1.2 MgCl2, 2.5 CaCl2, 1.2
NaH2PO4, 24.9 NaHCO3, and 11.5 glucose. Slices were then incubated at
36 C while perfused (1.5 ml/min) with oxygenated (95% O2- 5% CO2)2
aCSF. During incubation, aCSF solution contained the following synaptic
receptor antagonists: the selective NMDA receptor antagonist 2-amino-5-
phosphonovaleric acid (APV, 40 μM), the competitive AMPA/kainate
glutamate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione
(CNQX, 10 μM), the glycine receptor antagonist strychnine (STR, 10
μM), the specific GABA-A receptor antagonist gabazine (GBZ, 10 μM),
and the nicotinic receptor antagonist mecamylamine (MEC, 10 μM)
collectively referred to here as synaptic blockers (SB). We also used the
sodium channel blocker tetrodotoxin (TTX, 3 μM).
These conditions mimicked those used for PPN patch clamp recording
studies of intrinsic gamma oscillations (Simon et al., 2010; Garcia-Rill
et al., 2011; Kezunovic et al., 2011; Hyde et al., 2013; Luster et al., 2015,
2016; Urbano et al., 2014, 2018), allowing us to analyze PPN intrinsic
properties and their role on gamma oscillations in total isolation from
synaptic inputs from their surrounding network of cells. All experimental
protocols were approved by the Institutional Animal Care and Use
Committee of the University of Arkansas for Medical Sciences and were
in agreement with the ‘‘Guidelines for the Care and Use of Mammals in
Neuroscience and Behavioral Research’’, used by the National Institutes
of Health for the care and use of laboratory animals.
2.2. Incubation or stimulation
Slices containing the PPNwere incubated in aCSF (unstimulated), and
compared to slices incubated with the cholinergic agonist carbachol
(CAR 50 μM) (stimulated), and each group was incubated in TSA for 30
min, providing TSA, CAR, and TSA þ CAR groups. Exposure to CAR is
known to induce gamma oscillations in PPN neurons (Kezunovic et al.,
2013), and is a well-known agent for activating PPN (for review see
Garcia-Rill, 2015). We based our working concentrations of HDAC in-
hibitors on previously published reports using neurons in vitro (Akhtar
et al., 2009; Calfa et al., 2012). Trichostatin A (TSA) at 1 μM was higher
than the lowest effective concentration used on dopaminergic neurons in
vitro (Hsu et al., 2016). That is, based on the differential affinities, the
final concentration used was 1 μM for TSA (6.5x IC50), which was
established as effective and without deleterious effects in our previous
studies (Urbano et al., 2018). No changes were observed after TSA (1 μM)
acute administration in voltage-dependence of calcium current I–V
curves (Urbano et al., 2018). Furthermore, TSA's rapid effects in vitro
might be due to the acetylation of multiple proteins located outside the
nucleus (Choudhary et al., 2009). Indeed, we have suggested that alter-
ations in the acetylation/deacetylation equilibrium may blunt the
Ca2þ-CAM kinase II homeostatic modulation of P/Q-type calcium chan-
nels (Urbano et al., 2018; Garcia-Rill et al., 2019). The stock solution of
TSA was dissolved in DMSO and immediately stored at -30 C. The final
concentration of DMSO in the incubation aCSF solution was <0.01%.
Control aCSF contained the same DMSO concentration as in control
unstimulated conditions. Slices were floated onto sterile petri dishes and
1 mm punch biopsies taken of the PPN under a dissection microscope at
x10. Biopsies were immediately inserted into sterile microcentrifuge
tubes and frozen in dry ice.
2.3. Proteomics
Brain slices from three animals per condition (total of 11 slices per
condition) were analyzed by high resolution mass spectrometry. We used
triplicate samples for the proteomics analysis. Extracted proteins were
reduced, alkylated, and digested using filter-aided sample preparation
(Wisniewski et al., 2009). Tryptic peptides were then separated by
reverse phase XSelect CSH C18 2.5 um resin (Waters) on an in-line 150
0.075 mm column using an UltiMate 3000 RSLCnano system (Thermo
Scientific). Peptides were eluted using a 90 min gradient from 97:3 to
60:40 buffer A (0.1% formic acid, 0.5% acetonitrile):B (0.1% formic acid,
99.9% acetonitrile) ratio. Eluted peptides were ionized by electrospray
(2.15 kV) followed by MS/MS analysis using higher-energy collisional
dissociation (HCD) on an Orbitrap Fusion Lumos mass spectrometer
S.D. Byrum et al. Heliyon 5 (2019) e02265(Thermo Scientific) in top-speed data-dependent mode. MS data were
acquired using the FTMS analyzer in profile mode at a resolution of 240,
000 over a range of 375–1500 m/z. Following HCD activation, MS/MS
data were acquired using the ion trap analyzer in centroid mode and
normal mass range with precursor mass-dependent normalized collision
energy between 28.0 and 31.0.
Proteins were identified by searching against the UniprotKB database
restricted to Rattus (July 2018 database; 8047 protein entries) using
Mascot (Matrix Science; version 2.5.1). Search parameters included fixed
modification set as carbamidomethyl on C, variable modifications set as
oxidation on M and acetyl on peptide N-terminal, parent ion tolerance of
3 ppm and a fragment ion tolerance of 0.5 Da. Scaffold (Proteome Soft-
ware) was used to verify MS/MS based peptide and protein identifica-
tions. Peptide identifications were accepted if they could be established
with less than 1.0% false discovery by the Scaffold Local FDR algorithm.
Protein identifications were accepted if they could be established with
less than 1.0% false discovery and contained at least 2 identified pep-
tides. Protein probabilities were assigned by the Protein Prophet algo-
rithm (Nesvizhskii et al., 2003).
Protein spectral counts were filtered so at least one sample had 5 or
more spectral counts, replaced missing values with 0.5, normalized the
counts to the normalized spectral abundance factor (NSAF) as described
in (Zybailov et al., 2006), and log2 transformed the data. The NSAF
formula is as follows: NSAF ¼ (spectral count/protein molecular
weight)/sum of (spectral counts/molecular weight). The sum included
the SC/MW for all proteins within the same sample. NSAF normalization
accounts for differences in larger and smaller proteins. Larger proteins
have a higher probability of detecting peptides vs smaller proteins and
therefore normalizing based on the length or molecular weight accounts
for this discrepancy. A student's t-test and fold change were calculated
using the log2 NSAF transformed data. We also provide ANOVA p-values
with Tukey post-hoc multiple comparisons test for comparing each
sample group. The full proteomics results are provided in Supplementary
Table 1. Proteins were considered significant with a p-value< 0.05. Data
visualization images were generated using Venny (version 2.1) for the
Venn Diagrams showing proteins identified, Bioconductor package
ComplexHeatmap in R, and plot function in R for the volcano plots.
3. Results
3.1. Population response recordings
Our previous studies using TSA found that either acute or prolonged
exposure to TSA reduced or eliminated intrinsic gamma oscillations in
single PPN neurons (Urbano et al., 2018). Such patch clamp studies
typically employ fast synaptic blockers (SBs) and tetrodotoxin (TTX),
such as used herein, for taking biopsies from the PPN. We carried out a
small study to determine the effects of TSA on slices without SBs and TTX.
The question is, does CAR induce gamma oscillations in the population as
a whole, and does TSA affect that network activity? We recorded popu-
lation responses from the PPN in slices stimulated by CAR (50 μM) before
and after exposure to TSA. Recordings were amplified with a Grass Inst.
(Quincy, MA) P511 amplifier, filtered at 1Hz-1KHz, and digitized with a
Digidata-1440 at a rate of 10 kHz. Averages of recordings and power
spectra were analyzed using pClamp10 software. Further analysis was
conducted using MatLab software (The MathWorks, Natick, MA). Plots of
the event related spectral perturbation (ERSP) for each population
response were generated with the EEGLAB MatLab Toolbox (Delorme
and Makeig, 2004). CAR was superfused for 10 min before TSA was
added for 10 min, and then CAR was continued without TSA for another
10 min Fig. 1 shows four brainstem slice population response recordings
from the PPN before and after TSA exposure. The ERSPs (left side) are
running power spectra over time from PPN population recordings in a
slice before (pre) and after (post) TSA exposure for 10 min. The power
spectra on the right are cumulative spectra for the entire 10 min. In both
ERSP and power spectra, it was clear that CAR alone (black record)3
induced a peak at gamma band frequencies (~35–40 Hz), while CAR
after TSA (red record) showed markedly decreased gamma band activity.
Changes in activity at other frequencies were variable. These results
suggest that the gamma band activity known to be induced in PPN
population response recordings by CAR (Simon et al., 2010; Garcia-Rill
et al., 2011) is markedly reduced by exposure to TSA.
3.2. Proteomics characterization
In order to identify the protein changes within the PPN due to TSA
and CAR exposure, we employed high resolution mass spectrometry.
Protein lysates were prepared from triplicate samples in four groups:
untreated brain slices, treated with TSA or CAR alone, and TSA in com-
bination with CAR. Protein lysates from the PPN were trypsin digested
into peptides using filter-aided sample preparation (FASP) (Wisniewski
et al., 2009). The peptides were separated on an in line reverse phase LC
column and peptides were eluted over a 90 min gradient. The spectra
were searched against the UniprotKB database restricted to Rattus in
Mascot. A total of 2,702 proteins were identified from all samples;
however, after filtering for low spectral counts (required at least one
sample with 5 or more spectral counts), a total of 1,721 proteins
were analyzed for differential expression. Of these identified proteins,
99.4% of the proteins were present in all four groups (Supplementary
Table 1).
After filtering, the spectral counts were normalized to Log2 NSAF for
differential expression. A student's t-test was used to calculate p-values
for three different comparisons: 1) Untreated vs TSA, 2) Untreated vs
CAR, and 3) Untreated vs TSA plus CAR to investigate protein changes in
TSA and CAR alone and in combination. Proteins with a p-value < 0.05
were considered significant. Of these, only 3.7% were significant in all
comparisons, regardless of treatment. There were 18.7%, 24.8%, and
36.1% significant proteins unique to each comparison: untreated PPN to
TSA, CAR, and TSA plus CAR, respectively (Supplementary Table 2).
A hierarchical cluster was generated using the Bioconductor package
ComplexHeatmap in R. The log2 NSAF values for proteins found to be
significantly differentially expressed by a p-value < 0.05 are visualized
and show clear separation of the sample groups; untreated vs TSA, un-
treated vs CAR, and untreated vs TSA plus CAR. TSA treatment had the
least amount of protein changes whereas the combination treatment had
the most. There were 101, 135, and 170 significant proteins for TSA,
CAR, and TSA plus CAR, respectively (Fig. 2, Supplementary Table 3).
Volcano plots help visualize the protein changes for each group
comparison; untreated vs TSA (Fig. 3A), untreated vs CAR (Fig. 3B), and
untreated vs TSA plus CAR (Fig. 3C). The log2 fold change (x-axis) and
–log10 p-value (y-axis) of each protein identified in each of the compar-
isons is shown. Significant proteins that are either up- or down-regulated
in the treatment are highlighted in red and blue, respectively. The hor-
izontal line indicates a p-value of 0.05.
4. Discussion
4.1. Caveats
We utilized a label-free proteomic workflow to provide an unbiased
and sensitive method to detect protein changes in the PPN. This approach
is superior to antibody-based, protein detection methods that can lack
specificity and can only be done for known targets in a lower throughput
manner. Proteomics methods, like the one used in this study, have been
leveraged to study molecular pathways in numerous systems and disease
states. For example, we have used similar approaches to characterize
molecular pathways in cancer (Byrum et al., 2013). Proteomics studies
on tissues can have cell specific limitations when the tissue sample is
limited and single cells cannot be isolated in enough abundance for
proteomic analysis. Here we circumvent that limitation by taking
advantage of specific blockers of gamma band oscillations (i.e., using
concentrations of TSA previously described to acutely block gamma
Fig. 1. Population responses in PPN. Left side. Population response recordings using low resistance (1–2 MΩ) electrodes in four individual slices containing the PPN
shown in ERSP form. Recordings shown were collected from different slices. Briefly, exposure to CAR before (pre) TSA showed significant levels of activity in the beta/
gamma range during the initial 10 min. After 10 min of TSA (not shown) it was discontinued, and CAR was superfused for another 10 min after TSA (post). In all cases,
gamma frequency activity was reduced and lower frequency activity became more pronounced, at least in some cases, but not all. These results suggest that TSA
reduced gamma band activity in the PPN network, despite being stimulated by CAR.
S.D. Byrum et al. Heliyon 5 (2019) e02265oscillation).
While our method appears to yield quite specific results on protein
expression, there are a number of other issues that need to be addressed.
Indeed, the proteins changes reported in this study require further sup-
port by alternative experimental means. In addition, the effects of TSA
are fairly broad and long lasting. Therefore, exposure for only 30 min
would seem to potentiate any lack of specificity. The fact that there were
a number of quite specific changes in protein expression would argue4
against an unspecific influence. Moreover, our previous studies showed
that the inhibitory effects of TSA on gamma oscillations began within
minutes, and they were mirrored by inhibition of histone deacetylase
(HDAC) IIa using MC1568, but there was no effect whenMS275was used
to block HDAC I (Urbano et al., 2018). That is, a targeted action on HDAC
IIa appeared responsible for the decrease in gamma activity. We also used
30 min pre-incubations with TSA to determine if longer exposure would
have the same effects, which was indeed what was found, and the effects
Fig. 2. Hierarchical clustering of differentially expressed proteins from exposure to TSA, CAR, and TSA þ CAR. The log2 NSAF values are shown for significantly
differentially expressed proteins between the untreated samples and TSA (A), CAR Act16b (B), and combination treatment with TSA þ CAR (C). Proteins were
considered significant with a t-test p-value < 0.05. The combination exposure had the most impact on the proteome.
S.D. Byrum et al. Heliyon 5 (2019) e02265were not potentiated or more widespread. In addition, those studies
employed synaptic blockers and sodium channel blockade, as well as
ramp stimuli, permitting only high threshold calcium channel-mediated
gamma oscillations. That is, there was no other activity present and thus
only gamma oscillations were affected by TSA and MC1568, but not
MS275. Population responses demonstrated that gamma band activity
was preferentially affected by TSA (Fig. 1). The results of the present
study, like those of our previous work (Urbano et al., 2018), demon-
strated changes in protein expression within minutes, but there certainly
are changes that occur within hours or perhaps days after TSA exposure.
While this is an acceptable pursuit, we are interested in the acute effects
of TSA, which is known to have soporific effects on patients, and its in-
hibition of gamma oscillations, which could certainly account for this
fairly rapid side effect.Fig. 3. Volcano plots depicting protein expression in each of the treatments; TSA (A),
axis) of each protein identified in each of the comparisons is shown. Significant prote
and blue, respectively. The horizontal line indicates a p-value of 0.05.
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Another issue is whether TSA is acting directly on the calcium
channels being studied. Previous results showed that calcium currents
were affected mostly in the plateau phase and not the early rapid phase
mediated by other types of calcium channels (Urbano et al., 2018),
suggesting not all calcium channels were affected. Moreover, we previ-
ously reported that it was PPN cells with P/Q-type calcium channels and
not N-type calcium channels in which gamma oscillation inhibition was
inhibited by TSA (Urbano et al., 2018). Interestingly, the present results
suggest that CAR, when exposed along with TSA, had intermediate ef-
fects, showing that the two agents competed for PPN cell activity. If TSA
acted directly on P/Q-type calcium channels, CAR would not demon-
strate competitive effects since it acts on cholinergic receptors. The re-
sults rather point to a balance between synaptic and intrinsic activity
modulating the action of PPN neurons intracellularly. Moreover, ourCAR (B), and TSA þ CAR (C). The log2 fold change (x-axis) and –log10 p-value (y-
ins that are either up- or down-regulated in the treatment are highlighted in red
S.D. Byrum et al. Heliyon 5 (2019) e02265previous study established that CaMKII blockade decreased the oscilla-
tions, once again pointing to an intracellular site of action (Urbano et al.,
2018). The question is, what is that intracellular mechanism by which
TSA and MC1568 affect gamma oscillations?
Interestingly, the most significant protein changes observed involved
two neuronal functions, known to be essential to the physiology of the
PPN: cytoskeletal and intracellular [Ca2þ] regulation. Interestingly, acute
treatment with TSA þ CAR altered a considerably larger number of
proteins, up- and down-regulating their levels, compared to acute TSA
treatment alone. Interestingly, CAR treatment augmented proteins levels
of actin-like proteins that increased actin polymerization. Understanding
whether these protein changes underlined the effects of TSA vs. TSA þ
CAR, or represented mechanisms of molecular compensation for the
cellular and physiological consequences of those treatments remains to
be elucidated.
4.2. Cytoskeleton
One interesting outcome of this work was the observed changes in
abundance of several proteins related to the actin cytoskeleton. Actin and
tubulin proteins are known to be functionally interrelated. Understand-
ing actin-tubulin interactions is essential to describing how neuronal
compartments integrate synaptic inputs with their intrinsic properties
(Coles and Bradke, 2015). Acute treatment with TSA increased actin-like
protein 6B, a nuclear protein involved in transcriptional activation and
repression of select genes by chromatin remodeling (Wu et al., 2007),
while decreasing the levels of F-actin capping protein beta, an inhibitor
F-actin polymerization (Coles and Bradke, 2015). These changes are
particularly important since F-actin bundles exert force on the plasma
membrane, stabilizing ion channel membrane expression while inter-
acting with tubulin microtubules (Coles and Bradke, 2015). TSA þ CAR
treatment increased actin-related protein 2/3 levels, which is known to
induce actin polymerization (Welch et al., 1997). TSA þ CAR treatment
also decreased several tubulin and actin associated proteins. As
mentioned above, altering F-actin protein levels would have a significant
impact on CaMKII-dependent gamma activity maintenance through its
direct involvement in CaMKII-beta and alpha subunit dimerization (Shen
et al., 1998), and their intracellular translocation (Shen and Meyer,
1999). Furthermore, TSA þ CAR treatment decreased the level of a
Kelch-like protein. Kelch-like proteins have been shown to positively
modulate P/Q-type calcium channel activity (Aromolaran et al., 2007;
Perissinotti et al., 2014). In agreement, the acute effects of TSA on PPN
rhythmicity were found to be mediated by an intracellular
CaMKII-dependent pathway (Urbano et al., 2018), and both TSA and
CAR have been previously found to blunt P/Q-type channel-mediated
calcium currents (Kezunovic et al., 2013; Urbano et al., 2018). In
conclusion, TSA was able to altered key cytoskeletal proteins levels and
membrane voltage-gated channels, which would result in a significant
blunting of PPN physiology. These results are in agreement with previ-
ously described acetylation changes in cytoskeleton proteins by SAHA
and MS275 HDAC inhibitors (Choudhary et al., 2009).
4.3. Intracellular [Ca2þ] regulation
TSA þ CAR treatment boosted the levels of several proteins related to
intracellular [Ca2þ] regulation like hippocalcin. Hippocalcin is a protein
that acts as a sensor of intracellular [Ca2þ] transients after binding to the
plasma membrane (Tzingounis et al., 2007). Neurocalcin protein levels
were increased by acute treatment with TSA and TSA þ CAR. Neuro-
calcin is a plasma-binding intracellular [Ca2þ] sensor that facilitates the
slow after hyperpolarization of the neuronal membrane potential (Beven
et al., 2010), allowing for the normal recovery of membrane potential
after massive activation of voltage-gated calcium channels (e.g., after the
sustained activation of PPN gamma oscillations).
Acute TSA treatment also reduced the levels of neuronal calcium
sensor 1 (NCS-1), a [Ca2þ] sensor over-expressed in the brain of bipolar6
disorders patients (Garcia-Rill et al., 2018), that has been observed to
modulate gamma band oscillations in PPN neurons (D'Onofrio et al.,
2015). acute TSA þ CAR treatment down-regulated the
voltage-dependent calcium channel α2δ subunit, an auxiliary subunit
known to support the membrane trafficking of P/Q-type calcium chan-
nels (Klugbauer et al., 2003).
In summary, the method developed can sample physiologically rele-
vant proteins involved in gamma band activity, which serves the most
complex of brain processes. These analyses provide detailed results that
help identify intracellular mechanisms involved in the acute regulation
and proteomics of gamma band activity.
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